INTRODUCTION AND OBJECTIVES:
The impact of positive margins after partial nephrectomy is controversial. The objective was to evaluate the impact of positive surgical margins after partial nephrectomy (PN), looking for factors that could explain them.
METHODS: A retrospective study of 388 patients that underwent partial nephrectomy at our institution (424 surgeries) between November 2005 and December 2016 was performed. Two groups were created: positive (PM) or negative (NM) margins groups after partial nephrectomy (PN). The SPSS Statistics 23.0 software was used: independent samples t-student, chi-square, logistic regression and log-rank were done. The p value<0.05 was considered statistically significant. RESULTS: Positive surgical margins rate was 3.8% (N[16). The age at surgery was 61.8AE13.0 years, with a male prevalence (N[270; 63.7% The warm ischemia time (PM: 13.8AE8.6 vs NM: 13.5AE9.8 min, p:0.9), surgery time (140.3AE56.5 vs 119.2AE43.5 min, p: 0.06) and hospitalization time (5.1AE1.9 vs 5.6AE1.9 days, p:0.8) had no association with PM. However, PM were more frequently seen after haemorrhagic surgeries (25 vs 7.6%, p:0.02).
Pathology 
To assess the positive surgical margin (PSM) rate and to investigate for its predictors in patients treated with partial nephrectomy (PN) for localized renal tumors in a large multicenter prospective observational study.
METHODS: We prospectively evaluated 4,308 patients who underwent surgical treatment for renal tumors between January 2013 and December 2016 at 26 urological Italian centres (the RECORd 2 project). PSM was assigned at pathological examination if the tumor tissue was marked with ink. Uni and multivariable analyses were fitted to identify independent predictors of PSM.
RESULTS: Overall, 2,076 patients treated with PN for localized renal cell carcinoma (RCC) were included. Median age was 62.6 (IQR: 54.7-72) and 69.5% (1443/2076) were males. Median PADUA score was 8 (IQR: 7-9). Simple enucleation (SE) and enucleoresection (ER) were performed in 722 (34.8%) and 1354 (65.2%) respectively. 1461 (70.4%), 405 (19.5%), 191 (9.2%) 2 (0.09%) and 17 (0.8%) had clear cell RCC, papillary RCC, chromophobe RCC, sarcomatoid RCC and unclassified RCC respectively. Upstaging to pT3a and lymphovascular invasion (LVI) were recorded in 164 (7.9%) and 95 (4.6%). Tumor necrosis and sarcomatoid differentiation were recorded in 342 (16.5%) and 22 (1.1%) with a median percentage of 30% (IQR 15%-65%) and 35% (IQR 15%-70%) within the tumor, respectively. PSM were recorded in 155 (4.9%) patients.
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